Prostatis Group’s Innovator Equity Defined Protection ETF - 1 Yr November ZNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.26M Buy
47,538
+25,271
+113% +$676K 0.32% 69
2025
Q4
$594K Buy
+22,267
New +$591K 0.14% 97

Other funds holding ZNOV

Prostatis Group's ZNOV Position: Q1 2026 in Review

Prostatis Group increased its Innovator Equity Defined Protection ETF - 1 Yr November (ZNOV) stake by 113% in Q1 2026, buying an estimated $676K and bringing the position to 47,538 shares worth $1.26M. The position accounts for 0.32% of the portfolio, ranked #69.

Prostatis Group first reported a position in ZNOV in Q4 2025 and has held it in 2 quarters since. 76 funds tracked by Wall St. Rank hold ZNOV as of Q1 2026.

  • Prostatis Group held 47,538 shares of Innovator Equity Defined Protection ETF - 1 Yr November worth $1.26M as of Q1 2026.
  • Prostatis Group bought 25,271 Innovator Equity Defined Protection ETF - 1 Yr November shares in Q1 2026, an estimated $676K.
  • Innovator Equity Defined Protection ETF - 1 Yr November made up 0.32% of Prostatis Group's portfolio in Q1 2026, its #69 holding.
  • Prostatis Group first reported a position in Innovator Equity Defined Protection ETF - 1 Yr November in Q4 2025 and has held it in 2 quarters since.
  • 76 funds tracked by Wall St. Rank held Innovator Equity Defined Protection ETF - 1 Yr November as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.